Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11872266 Rapid-acting insulin compositions

Patent 11872266 was granted and assigned to Eli Lilly and Company on January, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Eli Lilly
Eli Lilly
0
Date Filed
September 17, 2021
0
Date of Patent
January 16, 2024
0
Patent Applicant
Eli Lilly
Eli Lilly
0
Patent Application Number
17478747
0
Patent Citations
‌
US Patent 8318154 Super fast-acting insulin compositions
0
‌
US Patent 11123406 Rapid-acting insulin compositions
0
‌
US Patent 9901623 Rapid-acting insulin compositions
0
‌
US Patent 7279457 Rapid acting drug delivery compositions
0
‌
US Patent 7696162 Zinc-free and low-zinc insulin preparations having improved stability
0
‌
US Patent 7713929 Rapid acting and long acting insulin combination formulations
0
‌
US Patent 7713930 Acidic insulin preparations having improved stability
0
‌
US Patent 8084420 Rapid acting and long acting insulin combination formulations
0
Patent Inventor Names
Virender Kumar Sarin
0
Chad D. Paavola
0
Ranajoy Majumdar
0
Chi A. Nguyen
0
Nanette Elizabeth Schulte
0
Michael Patrick Akers
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11872266
0
Patent Primary Examiner
‌
Sergio Coffa
0

Find more entities like US Patent 11872266 Rapid-acting insulin compositions

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo